一項評估新型乳房影像系統的臨床試驗，將重點確定該系統用于早期癌癥檢查的附屬效率。

這套Sentinel乳房影像系統，是由美國紅外線科學集團公司（ISA）研制開發的，將再美國紐約Presbyterian醫院－Cornell大學Weill醫學院進行評估。研究參與人員將會按計劃在超聲或者乳房X線成像引導之下，接受乳房活檢。這項研究將評估病理學、放射學以及乳房影像系統結果的相關性。

ISA公司副總裁Matthew Campisi指出：“我們十分高興能夠開始與Cornell大學的研究，我們相信來自Sentinel系統的研究信息，將會證明這套系統能夠在對抗乳房癌的戰爭中發揮作用。Sentinel系統能夠為乳房健康信息提供嶄新的生理學資料，而這些資料不能從任何其它非創傷性檢測方法中獲得。”

Sentinel乳房掃描是一種無痛、無接觸、非創傷性檢查方法，適合任何年紀的女性。該技術是以尖端的數字紅外線影像技術為基礎的，同時聯合應用了人工智能的高級軟件。在4分鐘的檢查之后，即可為臨床醫生提供完整詳細而客觀的報告。

這套技術將作為附屬程序，而不會替代乳房X線檢查技術或者超聲檢查方法，或者用于確定乳房整體健康狀況而單獨使用。

Breast Imaging System
 
A clinical study to evaluate a new breast imaging system will focus on determining the adjunctive effectiveness of the system for early cancer detection.

The Sentinel BreastScan imaging system, developed by Infrared Sciences Corp. (ISC; Stony Brook, NY, USA), will be assessed at the New York Presbyterian Hospital-Weill Medical College of Cornell University (New York, NY, USA). Study participants will have been scheduled to undergo a breast biopsy, either by ultrasound or mammography. The study will correlate the outcomes of pathology, radiology, and the breast imaging system.

“We are pleased and excited to commence this study with Cornell, and we believe that the information obtained from the Sentinel system will prove it to be a highly effective adjunctive tool in the war against breast cancer,” noted Matthew Campisi, vice president, ISC. “The Sentinel system provides a new physiological dimension to breast health information that is not available from any other fully noninvasive testing material.”

The Sentinel BreastScan is a painless, touchless, noninvasive technique offered to women of any age. The technology is based on sophisticated digital infrared imaging that is combined with advanced software employing artificial intelligence methods. Immediately following the four-minute test, it provides the clinician with a fully-interpreted, objective report.

The technology is intended to be an adjunctive procedure and does not replace mammography or ultrasound, or stand alone as a single test that can determine overall breast health.